Based on this YouTube video's total view count of 169K views and industry-standard rates, the estimated total earning is $119 - $339 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.

Explore Taxpayers Funded a Life-Saving Drug. Now It's Unaffordable. with 169,363 views, 7,495 likes, and 1,453 comments. Experience the impact of this video content that has captured audience attention.

Merck is charging $200,000 for the life-saving cancer drug Keytruda. They’re making a fortune off it. But it was developed using tax-payer dollars. That means the federal government has the little-known power to lower the price by taking Merck’s patent and giving it away. WARNING: flashing images until 0:04 ----- More Perfect Union is a nonprofit media organizaton with a mission to build power for working people. Learn more here: http://perfectunion.us/ Follow us on Twitter: https://twitter.com/MorePerfectUS Instagram: https://www.instagram.com/perfectunion/ Facebook: https://www.facebook.com/MorePerfUnion Tiktok: https://www.tiktok.com/@moreperfectunion

With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.

Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.

Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.

Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.